MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 139 filers reported holding MACROGENICS INC in Q2 2020. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,588,991 | -10.6% | 770,170 | +2.6% | 0.00% | 0.0% |
| Q2 2023 | $4,014,581 | -20.6% | 750,389 | +6.5% | 0.00% | 0.0% |
| Q1 2023 | $5,053,545 | +4.1% | 704,818 | -2.6% | 0.00% | 0.0% |
| Q4 2022 | $4,854,088 | +83.2% | 723,411 | -5.5% | 0.00% | 0.0% |
| Q3 2022 | $2,650,000 | +56.8% | 765,916 | +33.8% | 0.00% | – |
| Q2 2022 | $1,690,000 | -67.6% | 572,413 | -3.4% | 0.00% | -100.0% |
| Q1 2022 | $5,220,000 | -47.8% | 592,510 | -4.8% | 0.00% | -50.0% |
| Q4 2021 | $9,992,000 | -24.9% | 622,552 | -2.0% | 0.00% | 0.0% |
| Q3 2021 | $13,304,000 | -23.8% | 635,351 | -2.2% | 0.00% | -33.3% |
| Q2 2021 | $17,448,000 | -10.3% | 649,636 | +6.4% | 0.00% | -25.0% |
| Q1 2021 | $19,441,000 | +30.4% | 610,413 | -6.4% | 0.00% | +33.3% |
| Q4 2020 | $14,907,000 | -9.4% | 652,137 | -0.1% | 0.00% | -25.0% |
| Q3 2020 | $16,447,000 | -7.0% | 652,841 | +3.1% | 0.00% | 0.0% |
| Q2 2020 | $17,687,000 | +389.4% | 633,477 | +2.0% | 0.00% | +300.0% |
| Q1 2020 | $3,614,000 | -45.6% | 621,106 | +1.7% | 0.00% | 0.0% |
| Q4 2019 | $6,645,000 | -19.1% | 610,707 | -5.1% | 0.00% | -50.0% |
| Q3 2019 | $8,215,000 | -13.0% | 643,820 | +15.7% | 0.00% | 0.0% |
| Q2 2019 | $9,444,000 | -4.6% | 556,503 | +1.1% | 0.00% | 0.0% |
| Q1 2019 | $9,896,000 | +48.6% | 550,414 | +4.9% | 0.00% | 0.0% |
| Q4 2018 | $6,661,000 | -40.6% | 524,500 | +0.3% | 0.00% | -33.3% |
| Q3 2018 | $11,210,000 | +5.7% | 522,856 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $10,609,000 | -2.7% | 513,756 | +18.5% | 0.00% | 0.0% |
| Q1 2018 | $10,907,000 | +32.8% | 433,523 | +0.3% | 0.00% | +50.0% |
| Q4 2017 | $8,213,000 | +3.3% | 432,223 | +0.4% | 0.00% | 0.0% |
| Q3 2017 | $7,953,000 | +4.9% | 430,363 | -0.6% | 0.00% | 0.0% |
| Q2 2017 | $7,580,000 | +2.1% | 432,878 | +8.5% | 0.00% | 0.0% |
| Q1 2017 | $7,422,000 | -5.2% | 398,964 | +4.2% | 0.00% | 0.0% |
| Q4 2016 | $7,825,000 | -31.1% | 382,793 | +0.9% | 0.00% | -50.0% |
| Q3 2016 | $11,351,000 | +12.4% | 379,536 | +1.4% | 0.00% | +33.3% |
| Q2 2016 | $10,102,000 | +48.1% | 374,272 | +2.9% | 0.00% | +50.0% |
| Q1 2016 | $6,819,000 | -38.1% | 363,670 | +2.2% | 0.00% | -50.0% |
| Q4 2015 | $11,021,000 | +48.4% | 355,837 | +2.6% | 0.00% | +100.0% |
| Q3 2015 | $7,427,000 | -19.2% | 346,743 | +43.3% | 0.00% | -33.3% |
| Q2 2015 | $9,188,000 | +32.4% | 241,985 | +9.4% | 0.00% | +50.0% |
| Q1 2015 | $6,941,000 | +0.8% | 221,292 | +12.7% | 0.00% | 0.0% |
| Q4 2014 | $6,886,000 | +61.5% | 196,348 | -3.7% | 0.00% | +100.0% |
| Q3 2014 | $4,263,000 | +117.3% | 203,951 | +125.8% | 0.00% | 0.0% |
| Q2 2014 | $1,962,000 | -9.1% | 90,315 | +16.4% | 0.00% | 0.0% |
| Q1 2014 | $2,159,000 | -0.6% | 77,584 | -2.1% | 0.00% | 0.0% |
| Q4 2013 | $2,172,000 | – | 79,216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,264,158 | $5,890,976 | 1.79% |
| Bellevue Group AG | 9,803,313 | $45,683,439 | 0.74% |
| Frazier Life Sciences Management, L.P. | 1,803,204 | $8,402,931 | 0.56% |
| DAFNA Capital Management LLC | 258,496 | $1,204,591 | 0.38% |
| SECTORAL ASSET MANAGEMENT INC | 387,001 | $1,803,425 | 0.35% |
| ARMISTICE CAPITAL, LLC | 4,712,000 | $21,957,920 | 0.34% |
| Rock Springs Capital Management LP | 1,178,796 | $5,493,189 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 225,918 | $1,053 | 0.09% |
| PINNACLE ASSOCIATES LTD | 697,067 | $3,248,332 | 0.06% |
| XTX Topco Ltd | 53,269 | $248,234 | 0.04% |